Tic Disorder and High Mycoplasma Levels in Children: A Case Study
Recent Advances in Clinical Trials · 28.02.2026 · 6 (1)
DOI: 10.33425/2771-9057.1078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Recent Advances in Clinical Trials, online erschienen am 28.02.2026. Verfasst von Lauren Sullivan.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
J.F. is a six-year-old male child with a new onset of transient tic disorder after having a mycoplasma infection. The child was evaluated by a pediatric neurologist, who confirmed the tic disorder but did not recommend treatment or followup. The primary health care team obtained lab work for Complete blood count (CBC), Comprehensive metabolic panel (CMP), Mycoplasma IgG/IgM, ASO, Anti-DNAse B antibody, sedimentation rate, Lyme ELISA and western blot, serum copper, iron, vitamin D 25 hydroxy, zinc and heavy metals. Labs were unremarkable except positive Mycoplasma IgG and IgM. Azithromycin was prescribed for five days and blood work was repeated for Mycoplasma antibodies 8 weeks after treatment.
Zitieren
APA
Sullivan, L. (2026). Tic Disorder and High Mycoplasma Levels in Children: A Case Study. Recent Advances in Clinical Trials, 6(1). https://doi.org/10.33425/2771-9057.1078
Vancouver
Sullivan L. Tic Disorder and High Mycoplasma Levels in Children: A Case Study. Recent Advances in Clinical Trials. 2026;6(1). doi:10.33425/2771-9057.1078
BibTeX
@article{Sullivan2026,
author = {Sullivan, Lauren},
title = {Tic Disorder and High Mycoplasma Levels in Children: A Case Study},
journal = {Recent Advances in Clinical Trials},
year = {2026},
volume = {6},
number = {1},
doi = {10.33425/2771-9057.1078}
}
EUVIMED